{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:09:05Z","timestamp":1770980945630,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.lungcan.2008.09.013","type":"journal-article","created":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T11:54:07Z","timestamp":1226663647000},"page":"124-126","source":"Crossref","is-referenced-by-count":9,"title":["Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer"],"prefix":"10.1016","volume":"64","author":[{"given":"Joaquim","family":"Bosch-Barrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"L\u00f3pez-Picazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Garc\u00eda-Foncillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Yuste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Gil-Bazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 Suppl. 6","key":"10.1016\/j.lungcan.2008.09.013_bib1","first-page":"42","article-title":"Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis","volume":"26","author":"Mendelsohn","year":"1999","journal-title":"Semin Oncol"},{"issue":"9","key":"10.1016\/j.lungcan.2008.09.013_bib2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"issue":"Suppl. 5","key":"10.1016\/j.lungcan.2008.09.013_bib3","doi-asserted-by":"crossref","first-page":"v86","DOI":"10.1093\/annonc\/mdj958","article-title":"Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer","volume":"17","author":"Monnerat","year":"2006","journal-title":"Ann Oncol"},{"issue":"2 Pt 1","key":"10.1016\/j.lungcan.2008.09.013_bib4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/1078-0432.690.11.2","article-title":"Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial","volume":"11","author":"Scagliotti","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.lungcan.2008.09.013_bib5","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/cncr.21480","article-title":"Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer","volume":"104","author":"Zinner","year":"2005","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.lungcan.2008.09.013_bib6","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2008.09.013_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2006.04.005","article-title":"Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial","volume":"53","author":"Treat","year":"2006","journal-title":"Lung Cancer"},{"issue":"25","key":"10.1016\/j.lungcan.2008.09.013_bib8","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1200\/JCO.2005.13.953","article-title":"Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer","volume":"23","author":"Ma","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2008.09.013_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.lungcan.2005.10.008","article-title":"Pemetrexed-associated urticarial vasculitis","volume":"51","author":"Lopes","year":"2006","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2008.09.013_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0761-8425(07)91133-X","article-title":"Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer","volume":"24","author":"Tummino","year":"2007","journal-title":"Rev Mal Respir"},{"issue":"4","key":"10.1016\/j.lungcan.2008.09.013_bib11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1200\/JCO.1999.17.4.1194","article-title":"Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: a phase II study. National Cancer Institute of Canada Clinical Trials Group","volume":"17","author":"Rusthoven","year":"1999","journal-title":"J Clin Oncol"},{"issue":"November (11)","key":"10.1016\/j.lungcan.2008.09.013_bib12","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.lungcan.2008.09.013_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2005.042143","article-title":"Diagnosis and management of adult onset Still's disease","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.lungcan.2008.09.013_bib14","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.lungcan.2008.09.013_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still's disease clinical course and outcome.","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.lungcan.2008.09.013_bib16","first-page":"827","article-title":"Adult onset Still's disease","volume":"13","author":"Calabro","year":"1986","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.lungcan.2008.09.013_bib17","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1378\/chest.115.6.1738","article-title":"Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy","volume":"115","author":"Iglesias","year":"1999","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lungcan.2008.09.013_bib18","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.lungcan.2008.09.013_bib19","first-page":"1","article-title":"Adult-onset Still's disease","volume":"49","author":"Cush","year":"2000","journal-title":"Bull Rheum Dis"},{"issue":"7","key":"10.1016\/j.lungcan.2008.09.013_bib20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10067-006-0440-x","article-title":"Ten years of clinical experience with adult onset Still's disease: is the outcome improving","volume":"26","author":"Uppal","year":"2007","journal-title":"Clin Rheumatol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208005060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208005060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T02:50:56Z","timestamp":1684637456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500208005060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0169500208005060"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2008.09.013","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}